Ellen T Chang1,2, Weimin Ye3, Yi-Xin Zeng4,5, Hans-Olov Adami6,7. 1. Center for Health Sciences, Exponent, Inc., Menlo Park, California. echang@exponent.com. 2. Department of Cancer Prevention Center, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China. 3. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 4. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, and Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China. 5. Beijing Hospital, Beijing, P.R. China. 6. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 7. Clinical Effectiveness Group, Institute of Health and Society, University of Oslo, Oslo, Norway.
Authors: Oscar Emanuel; Jacklyn Liu; Volker H Schartinger; Wen Long Nei; Yuk Yu Chan; Chi Man Tsang; Herbert Riechelmann; Liam Masterson; Johannes Haybaeck; Udo Oppermann; Stefan M Willems; Marc L Ooft; Guido Wollmann; David Howard; Bart Vanhaesebroeck; Valerie J Lund; Gary Royle; Melvin L K Chua; Kwok Wai Lo; Pierre Busson; Matt Lechner Journal: Cancers (Basel) Date: 2021-09-30 Impact factor: 6.639